Education
About Us
Working with TipRanks
Follow Us
Tilray (DE:2HQ0)
NASDAQ:2HQ0
2HQ0 Stock Chart & Stats
€6.00
--
Market closed
€6.00
--
Day’s Range― - ―
52-Week Range€2.81 - €19.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.26K
Market Cap
€700.02M
Enterprise Value€799.48M
Total Cash (Recent Filing)€407.29M
Total Debt (Recent Filing)€446.52M
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Apr 14, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding116,506,910
10 Day Avg. Volume3,236
30 Day Avg. Volume3,260
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€8.37Price Target Upside39.46% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)-0.41
Revenue Forecast (FY)€739.37M
Bulls Say, Bears Say
Bulls Say
Scaled Revenue & Distribution MomentumTilray has meaningfully scaled top-line, with record quarterly revenue driven by international cannabis and distribution growth. Sustained revenue scale and diversified channels (medical, distribution, international) deepen market reach and support durable margin expansion opportunities.
Project 420 Cost Savings & Reaffirmed GuidanceConcrete, multi-year cost reductions improve structural profitability if fully realized. Project 420 reduces fixed and operating costs, raising the floor on margins and making management's EBITDA targets more credible—supporting sustainable cash generation if execution continues.
Acquisition Expands Beverage Platform (BrewDog)Acquiring BrewDog assets is a durable strategic shift into branded craft beer, adding IP, pubs and UK/IR footprint. If integrated well, it accelerates international beverage scale, complementary revenue streams and branded CPG leverage across distribution and marketing investments.
Bears Say
Weak Cash GenerationPersistent negative operating and free cash flow requires ongoing external funding and limits self‑funding for capex, M&A or brand investments. Continued cash burn raises dilution and refinancing risk, constraining durable reinvestment and long-term financial flexibility.
Beverage Underperformance & Integration RiskThe beverage segment has underperformed and awaits portfolio fixes; integrating BrewDog assets increases complexity. Protracted turnarounds or failed integration would depress margins and consume capital, making beverage a structural drag on consolidated profitability for months to years.
Regulatory & Permit UncertaintyOngoing permit delays in Europe and unresolved U.S. hemp THC rules create structural revenue volatility and potential market access loss. Regulatory shifts can permanently alter addressable markets or require costly compliance changes, undermining long-term growth projections.
Tilray News
2HQ0 FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was €2.81 and its highest was €19.88 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is €700.02M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Apr 14, 2026 which is in 29 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Jan 08, 2026. The company reported -€0.358 earnings per share for the quarter, missing the consensus estimate of -€0.187 by -€0.171.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.12.
How many shares outstanding does Tilray have?
Tilray has 116,506,910 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -€0.358 in its last earnings report, missing expectations of -€0.187. Following the earnings report the stock price went up 1.883%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in DE:2HQ0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€8.37 (39.46% Upside)
€8.37 (39.46% Upside)
Blogger Sentiment
Neutral
DE:2HQ0 Sentiment 50%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.95%
12-Months-Change
Fundamentals
Return on Equity
-114.12%
Trailing 12-Months
Asset Growth
-49.94%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
2HQ0 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple meaningful operational and financial improvements: record quarterly revenue, stronger international cannabis and distribution growth, improved margins in cannabis and distribution, a markedly stronger cash position and a significant reduction in operating cash burn and net loss year-over-year. Key execution risks remain, notably beverage segment underperformance, ongoing GAAP net losses, regulatory uncertainty (particularly U.S. hemp-derived THC) and permit/price pressure in parts of Europe. On balance, management emphasized concrete progress, cost savings, reaffirmed guidance and strategic readiness for regulatory shifts, while acknowledging areas still requiring work.View all DE:2HQ0 earnings summaries2HQ0 Stock 12 Month Forecast
Average Price Target
€8.37
▲(39.46% Upside)
Options Prices
Currently, No data available
---